COMMUNIQUÉS West-GlobeNewswire

Canadians Want Professional Women’s Sport. Most Fans Don’t Know Where to Find it.
27/10/2026
New Canadian Women & Sport research finds demand is proven, but visibility is holding back the market’s next phase of growth TORONTO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Three in four Canadians (75%) now identify as [...]
Les Canadiens souhaitent assister à des événements sportifs féminins professionnels. La plupart des amateurs ignorent cependant où les trouver.
27/10/2026
Une nouvelle étude de Femmes et sport au Canada révèle que la demande est avérée, mais que le manque de visibilité freine la prochaine phase de croissance du marché TORONTO, 27 oct. 2026 (GLOBE NEWSWIRE) -- Trois [...]
1104Health and Johns Hopkins Researchers Present Data on Physician Collaboration Across Community and Academic Oncology
27/10/2026
Across 24 oncology organizations, findings highlight new physician relationships, rapid access to subspecialty expertise, and changes in patient management BALTIMORE, Oct. 27, 2026 (GLOBE NEWSWIRE) -- 1104Health, which [...]
AdipoPharma Advances PATAS into Phase 1b Clinical Trial in Patients with Type 2 Diabetes
27/10/2026
First participants with Type 2 diabetes dosed in multiple ascending dose (MAD) study evaluating AdipoPharma’s first-in-class insulin sensitizer Advancement follows successful completion of the single ascending dose (SAD [...]
AscellaHealth Executive Manager Wins 2026 Herizon Award, Recognizing Established Leadership in Team and Department Transformation
27/10/2026
BERWYN, Pa., Oct. 27, 2026 (GLOBE NEWSWIRE) -- AscellaHealth , a pharmacy benefits solutions company combining specialty healthcare expertise and technology to help payers optimize costs, streamline operations and [...]
National NUCCA doctors highlight importance of spinal health for daily function, better quality of life during World Spine Day observance
27/10/2026
SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- This month in honor of World Spine Day (Oct. 16), NUCCA doctors are highlighting how upper cervical alignment impacts the body's overall health and function. But despite the [...]
Fort Collins Oral and Maxillofacial Surgeon Dr. Daetwyler Provides Free Dental Care in Cripple Creek
27/10/2026
FORT COLLINS, Colo. and CRIPPLE CREEK, Colo., Oct. 27, 2026 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) recognizes its surgeon partner Michael Daetwyler , DDS – as he completes medical mission work in [...]
Acentra Health Names Mihriban Brickner as Senior Vice President of Operations
27/10/2026
Experienced healthcare operations leader will drive company's key Integrated Health Solutions initiatives and support clients MCLEAN, Va., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health [...]
Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers
27/10/2026
GOBLET Cohort 4 demonstrates approximately 15-month median duration of response that exceeds historical results for approved second-line checkpoint inhibitor monotherapy 100% of responding patients survived for longer [...]
Coherus to Participate in Upcoming Investor Conferences
27/10/2026
REDWOOD CITY, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ: CHRS), today announced that the company will be webcasting its participation in the following upcoming investor conferences: [...]
Egetis Therapeutics Announces U.S. Launch of EMCITATE® for Patients with MCT8 Deficiency
27/10/2026
EMCITATE is the first and only FDA-approved treatment for peripheral thyrotoxicosis in adults and pediatric patients with MCT8 deficiency in the United States Egetis RareLink™, the dedicated patient support program, [...]
The Gene Lay Institute of Immunology and Inflammation Expands World-Class Research Leadership, Appointing Four New Members
27/10/2026
Drs. Marco Colonna, Francisco J. Quintana, Howard L. Weiner, and Jun R. Huh join to advance clinical discovery in cross-system immunology. BOSTON, Oct. 27, 2026 (GLOBE NEWSWIRE) -- The Gene Lay Institute of Immunology [...]
aTyr Pharma Announces One-for-40 Reverse Stock Split
27/10/2026
aTyr’s common stock to begin trading on a post-split adjusted basis on October 29, 2026 SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage [...]
Emerging Digital Health Companies Choose HealthEx’s Platform and Health Records API to Personalize User Experiences with Clinical Context
27/10/2026
Companies in AI health coaching, rare disease care, caregiving, clinical trial matching and more build on the HealthEx health records API and MCP server to bring patients’ consented medical records from 90% of U.S. care [...]
Exagen to Announce Third Quarter Financial Results on November 10, 2026
27/10/2026
CARLSBAD, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2026, before the [...]
Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments
27/10/2026
English-language call at 8:30 a.m. Eastern Time and Hebrew-language call at 11:00 a.m. Israel Time on Thursday, October 29, 2026 HAIFA, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq and TASE: PLUR) (“ [...]
NorthStar Day Program, First of Its Kind in the Southeast, to Open in Palm Beach Gardens on November 4, 2026
27/10/2026
Innovative multidisciplinary program brings education, therapy, psychiatry and behavioral health services together under one roof for neurodivergent children ages 5–12 PALM BEACH GARDENS, Fla., Oct. 27, 2026 (GLOBE [...]
Nexalin Technology Announces Fourth Peer-Reviewed Publication in Alzheimer's Disease: 15 mA DIFS™ Significantly Improves Sleep Quality in Patients with Mild Alzheimer's Disease
27/10/2026
Results from the randomized, double-blind, sham-controlled TRANSFORM-AD study published in the Journal of Alzheimer's Disease, a recognized international peer-reviewed journal Statistically significant improvement in [...]
Syncromune Reports Long-Term Data from Phase 1 Study in Metastatic Prostate Cancer with Investigational SYNC-T Therapy SV-102
27/10/2026
Data support potential for highly differentiated clinical impact for patients suffering from metastatic prostate cancer 50% of patients who achieved a complete response (n=6) remain disease-free more than two years [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum